NewsRoom Articles - Page 310 of 1390

ThursdayMay 12, 2022 11:00 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Positioned for Growth Amid Compelling Market Opportunities for Expansion; Reports Financial Results

Tackling climate change opens up potentially compelling opportunities for growth for businesses driven by ESG values such as EverGen Company is eyeing growth opportunities – both nationally and internationally – as RNG gathers steam in the world’s bid to combat climate threat EverGen aims to unite social and environmental responsibility with market success; reports quarterly and annual financial results, announces plans to expand project pipeline EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), an established independent renewable natural gas producer based in Canada, appears ready for rapid growth as the Company seeks opportunities to expand its market presence amid the strong global…

ThursdayMay 12, 2022 9:30 am

SPYR Inc. (SPYR) Announces Plans to Boost Shareholder Value Through Market Expansion, Product Upgrades

SPYR Inc. is a Texas-based company dedicated to delivering quality in-demand Internet of Things (“IoT”) products for smart home and auto consumers of Apple products The company’s flagship products are developed by subsidiary Applied Magix, which also sources white label Apple HomeKit(TM) products and accessories SPYR recently announced evaluation of potential expansion into Mexico, Central Europe and Thailand to extend its global reach beyond its U.S. operations and its representative office in Hong Kong The company is also sharply discounting many of its products in a summer sale as it prepares to develop new upgraded versions SPYR has also announced…

WednesdayMay 11, 2022 12:00 pm

Alternative Products Expo At Medellin, Colombia, To Promote The Local Business Community

Alternative Products Expo is coming to Medellín, Colombia, on May 21-22nd 2022. A leading organizer in the alternative industry, they’re committed to serving the community and strive to provide an exciting learning experience in a safe and conducive environment. For one, exhibitors can showcase their products, expand their market reach, and get discovered by investors and industry professionals. Sponsored by JuicyFields.io, this event is expecting 100+ vendors and 1000+ products, including other sponsoring brands such as LightFire & EZ Delta 8 Wholesale. A one-of-a-kind networking event, at Alt Pro Expo, buyers and investors seeking profitable avenues can discover some of…

WednesdayMay 11, 2022 11:30 am

How to Win with Online Gambling

NetworkNewsWire Editorial Coverage: Luck is a huge aspect of gambling, but luck has a way of favoring the intelligent and showing its back to the foolish. Good online gamblers look for opportunities to improve their odds, then press when probabilities are in their favor. Luck is a fickle mistress and good gamblers know that luck is what happens when preparation meets opportunity. The seduction of gambling dates as early as 200 BC and now flourishes on PCs and mobile devices around the world. Eclipsing $70 billion last year, major casinos and new gaming platforms are fighting for a piece of…

WednesdayMay 11, 2022 11:15 am

Silo Pharma Inc. (SILO) Spotlight: Ketamine

Ketamine shows promise in treating Alzheimer’s Disease, Parkinson’s Disease as well as depression, suicide ideation and more In 2021, Silo Pharma (OTCQB: SILO) entered into a joint venture with Zylö Therapeutics to “explore the clinical development of ketamine using ZTI’s Z-pod (transdermal) technology.” This innovative technology allows Silo, an early-stage biopharmaceutical company, to develop a ketamine delivery system for those suffering dysphagia, a difficulty or complete inability to swallow.(1) Silo Pharma is exploring the efficacy of ketamine in treating patients suffering from both Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”). Over 80% of PD patients(2) and 75% of AD patients(3)…

WednesdayMay 11, 2022 10:30 am

Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

CNS Pharmaceuticals is developing a proprietary drug candidate that has the potential to deliver a novel solution for unmet medical needs in treating an incurable brain cancer CNS’s drug candidate is called Berubicin, a powerful anthracycline that appears to be the first such chemotherapy agent able to successfully cross the blood-brain barrier Berubicin dosing has begun in a potentially pivotal global trial that is recruiting glioblastoma multiforme (“GBM”) brain cancer patients The FDA has granted CNS fast-track authorization in regard to Berubicin’s development, and European countries’ drug regulatory bodies are also granting authorization to advance the trial process there An…

WednesdayMay 11, 2022 9:45 am

Friendable Inc. (FDBL) Provides Independent Artists 360 Anti-Label Platform for Music Creation, Distribution, and Promotion

Fan Pass Live with Artist Republik and FeaturedX is creating a 360 platform with pricing that sets them apart from competitors The May contest on Instagram is underway, and features Grow with Us (“GWU”) campaigns to help artists build their fanbase on Spotify/Soundcloud In the first 100 days, positive growth has been reflected across revenue per subscriber, spend per customer, and subscriber lifetime value Key metrics for social media have also seen an increase across the board In the five months since announcing the acquisition of Artist Republik (and FeaturedX), Friendable (OTC: FDBL), and its flagship offering, Fan Pass Live…

WednesdayMay 11, 2022 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Influencing the Pharmaceutical Industry

Lexaria began its human clinical study on oral nicotine alternatives, evaluating the effectiveness of its DehydraTECH-nicotine pouch performance Earlier in the year, the company also announced the commencement of its HYPER-H21-4 human clinical study on the effectiveness of DehydraTECH-processed CBD for hypertension treatment Lexaria has also made some significant progress in the use of its technology for the enhanced delivery of antiviral drugs It hopes that before the end of 2022, it will have built sufficient data to effect meaningful industry progress and sustainable increases in valuation Lexaria Bioscience (NASDAQ: LEXX), since its inception, has been pushing the boundaries of…

TuesdayMay 10, 2022 1:30 pm

DGE’s 2nd PRC Performance Optimization Summit to Offer Insights on Range of PRC Best Practices

Dynamic Global Events (“DGE”) invites you to the 2nd Promotional Review Committee (“PRC”) Performance Optimization Summit, regarded as the largest, most detailed PRC conference available. Slated for May 23-25, the three-day online livestream event is designed for all the cross-functional professionals working on review teams, including legal, medical communications, public relations, marketing, product management, brand management, editors, compliance, art, scientific communications, and more. The summit provides PRC best practices for team management and cooperation, maintaining regulatory compliance, and adapting to new technologies and platforms. Promotional review professionals face many challenges as they craft fair and accurate product messages that must…

TuesdayMay 10, 2022 12:45 pm

O’Cannabiz Conference Expo & Awards to Feature a Broad Spectrum of Cannabis Products and Services

ND Supplies presents the 3-day O’Cannabiz Conference Expo & Awards, June 1-3, 2022, at the Toronto International Centre this year. Voted the No. 1 Cannabis Event in Canada by High Canada Magazine, the O’Cannabiz International Conference returns as an in-person event, after being canceled last year. The event organizers are thankful to the partners, sponsors, and exhibitors for their patience and co-operation. The event is being touted as the most sort after cannabis conference in North America featuring Cannabis trade shows, retail summits, awards functions along with global-level networking opportunities among the veterans and dignitaries of the cannabis spectrum in Canada.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000